Clinical Trials Browser

Phase 4 × regorafenib × Gastrointestinal × Clear all

NCT04874207 2025-08-08

RePERSO

Phase 4 Completed

Gastrointestinal

Colorectal Cancer Metastatic

NCT03564938 2024-12-03

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Phase 4 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02800330 2018-08-02

REGORA

Phase 4 Completed

GastrointestinalSarcoma

Colorectal Neoplasms, Gastrointestinal Stromal Tumors